-
Fund Dashboard
- Holdings
Horizon Kinetics Medical ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 2.85 mm | 3.22 k shares | 16.33 | Common equity | Long | USA |
US BANK MMDA - USBGFS 7 | 1.75 mm | 1.75 mm shares | 10.02 | Short-term investment vehicle | Long | USA |
ABBV AbbVie Inc. | 1.45 mm | 7.36 k shares | 8.32 | Common equity | Long | USA |
NVS Novartis AG | 1.06 mm | 9.19 k shares | 6.06 | Common equity | Long | Switzerland |
AMGN Amgen Inc. | 1.04 mm | 3.22 k shares | 5.94 | Common equity | Long | USA |
AZN AstraZeneca PLC | 931.18 k | 11.95 k shares | 5.33 | Common equity | Long | UK |
BMY Bristol-Myers Squibb Company | 880.05 k | 17.01 k shares | 5.04 | Common equity | Long | USA |
JNJ Johnson & Johnson | 792.96 k | 4.89 k shares | 4.54 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 758.81 k | 2.76 k shares | 4.35 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 730.87 k | 6.44 k shares | 4.19 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 725.36 k | 690.00 shares | 4.15 | Common equity | Long | USA |
PFE Pfizer Inc. | 718.41 k | 24.82 k shares | 4.11 | Common equity | Long | USA |
ALKS Alkermes plc | 617.63 k | 22.07 k shares | 3.54 | Common equity | Long | Ireland |
BIIB Biogen Inc. | 579.19 k | 2.99 k shares | 3.32 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 478.80 k | 11.95 k shares | 2.74 | Common equity | Long | USA |
CRSP CRISPR Therapeutics AG | 475.16 k | 10.11 k shares | 2.72 | Common equity | Long | Switzerland |
GSK GSK plc | 441.18 k | 10.79 k shares | 2.53 | Common equity | Long | UK |
BCYC Bicycle Therapeutics plc | 312.11 k | 13.79 k shares | 1.79 | Common equity | Long | UK |
NTLA Intellia Therapeutics, Inc. | 283.43 k | 13.79 k shares | 1.62 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 225.25 k | 9.19 k shares | 1.29 | Common equity | Long | USA |
REPL Replimune Group, Inc. | 151.16 k | 13.79 k shares | 0.87 | Common equity | Long | USA |
HLN Haleon plc | 142.73 k | 13.49 k shares | 0.82 | Common equity | Long | UK |
GALT Galectin Therapeutics Inc. | 141.58 k | 51.48 k shares | 0.81 | Common equity | Long | USA |
VNDA Vanda Pharmaceuticals Inc. | 116.42 k | 24.82 k shares | 0.67 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 103.46 k | 30.34 k shares | 0.59 | Common equity | Long | USA |
LTRN Lantern Pharma Inc. | 101.23 k | 27.58 k shares | 0.58 | Common equity | Long | USA |
GEHC GE HealthCare Technologies Inc. | 86.34 k | 920.00 shares | 0.49 | Common equity | Long | USA |
TSVT 2seventy bio, Inc. | 78.12 k | 16.55 k shares | 0.45 | Common equity | Long | USA |
SDZNY Sandoz Group AG | 76.55 k | 1.84 k shares | 0.44 | Common equity | Long | Switzerland |
ALLO Allogene Therapeutics, Inc. | 51.49 k | 18.39 k shares | 0.29 | Common equity | Long | USA |
VTRS Viatris Inc. | 39.73 k | 3.42 k shares | 0.23 | Common equity | Long | USA |
NxStage Medical, Inc. | 18.76 k | 11.03 k shares | 0.11 | Common equity | Long | USA |
BLUE bluebird bio, Inc. | 18.15 k | 34.94 k shares | 0.10 | Common equity | Long | USA |
MURA Mural Oncology plc | 6.91 k | 2.21 k shares | 0.04 | Common equity | Long | Ireland |
SLRX Salarius Pharmaceuticals, Inc. | 5.36 k | 3.72 k shares | 0.03 | Common equity | Long | USA |
Pathos AI Inc
|
0.00 | 23.99 k shares | 0.00 | Common equity | Long | USA |